Karen Dixon
Nurse Practitioner · Athens, GANPI 1427401298
Payments from drug & device makers
Across 332 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Bayer$595
- AstraZeneca$482
- Sanofi-aventis U.S. LLC$385
- GSK$353
- Amgen$344
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,381100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 115 | $1,345 |
| Bayer | 35 | $595 |
| AstraZeneca | 27 | $482 |
| Sanofi-aventis U.S. LLC | 20 | $385 |
| GSK | 20 | $353 |
| Amgen | 20 | $344 |
| Lilly USA, LLC | 18 | $256 |
| AbbVie(2 entities) | 13 | $251 |
| Esperion Therapeutics, Inc. | 10 | $212 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Amarin Pharma, Inc. | 7 | $120 |
| Boehringer Ingelheim | 6 | $118 |
| Edwards Lifesciences | 5 | $108 |
| Abbott | 5 | $93 |
| Astellas Pharma US Inc | 4 | $92 |
| Dexcom, Inc. | 3 | $70 |
| Corcept Therapeutics | 3 | $67 |
| Exact Sciences | 3 | $59 |
| Johnson & Johnson | 3 | $50 |
| Pfizer | 2 | $48 |
| Saluda Medical Americas, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$121
How this compares
$5,382 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 121 | $138,668 |
| RybelsusSemaglutide | 49 | $82,118 |
| FarxigaDapagliflozin Propanediol | 60 | $69,935 |
| MounjaroTirzepatide | 44 | $68,358 |
| JardianceEmpagliflozin | 35 | $45,021 |
| EliquisApixaban | 20 | $28,398 |
| TrulicityDulaglutide | 13 | $27,037 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $26,967 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 19 | $23,551 |
| VascepaIcosapent Ethyl | 23 | $21,923 |
| JanuviaSitagliptin Phosphate | 14 | $20,721 |
| XareltoRivaroxaban | 19 | $18,233 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $17,126 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $16,803 |
| Repatha SureclickEvolocumab | 12 | $11,226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,345 | $220,786170 claims |
| Lilly USA, LLCMounjaro, Trulicity | $256 | $95,39657 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $482 | $90,06397 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $118 | $50,59646 claims |
| PfizerEliquis | $48 | $28,39820 claims |
| GSKTrelegy Ellipta | $353 | $26,96714 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $385 | $23,55119 claims |
| Johnson & JohnsonXarelto | $50 | $18,23319 claims |
| AbbVieLinzess | $251 | $10,06120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Athens
- Sue PhelpsAthens$14K
- Andrea MealorAthens$10K
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.